Milrinone or Dobutamine for Cardiogenic Shock?

September 27, 2021 • 00:25:40
Milrinone or Dobutamine for Cardiogenic Shock?
Critical Care Perspectives in Emergency Medicine
Milrinone or Dobutamine for Cardiogenic Shock?

Sep 27 2021 | 00:25:40

/

Show Notes

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data to guide optimal management and selection of agents.  In this podcast we discuss the results of a recent trial that compared milrinone with dobutamine for patients with cardiogenic shock.  Which agent was the winner?

You can get CME credit for this episode hereClick here for CME Account Creation Instructions

Other Episodes

Episode

February 06, 2018 • 00:22:23
Episode Cover

Reversal Strategies for Life-threatening Bleeding due to DOACs!

He's back!  Bryan Hayes joins the podcast to discuss the latest evidence pertaining to the reversal of life-threatening hemorrhage secondary to the direct oral...

Listen

Episode 0

July 01, 2021 • 00:26:54
Episode Cover

The TTM2 Trial

Current international guidelines recommend TTM for adult patients with ROSC from OHCA who remain comatose or unable to follow verbal commands.  However, the overall...

Listen

Episode 0

July 28, 2023 • 00:26:16
Episode Cover

Should We Transfuse Platelets Prior to CVC Placement?

Central venous catheter (CVC) placement is common in critically ill patients for a variety of indications.  Thrombocytopenia is also quite common in critically ill...

Listen